United Therapeutics
UTHR
#957
Rank
C$35.68 B
Marketcap
C$837.98
Share price
-0.32%
Change (1 day)
26.67%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): C$40.04

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$40.91. In 2025 the company made an earnings per share (EPS) of C$43.16 an increase over its 2024 EPS that were of C$37.82.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$40.04-7.23%
2025C$43.1614.1%
2024C$37.8225.59%
2023C$30.1231.54%
2022C$22.8951.18%
2021C$15.14-9.1%
2020C$16.66-581.4%
2019C-$3.46-117.79%
2018C$19.4542.11%
2017C$13.69-40.93%
2016C$23.1713.45%
2015C$20.42104.29%
2014C$10.00100.29%
2013C$4.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-97.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.17 7.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.02-104.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.43-110.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$11.10-72.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.11-89.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
C-$8.64-121.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.64-98.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel